Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice

被引:33
作者
Ito, H [1 ]
Ono, K [1 ]
Nishio, R [1 ]
Sasayama, S [1 ]
Matsumori, A [1 ]
机构
[1] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, Kyoto 6068397, Japan
关键词
amiodarone; immunomodulatory properties; interleukin; 6; viral myocarditis;
D O I
10.1006/cyto.2001.0996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A recent study has shown that amiodarone inhibits the production of cytokines in vitro. This study was performed to examine the effects of amiodarone on survival, heart weight-to-body-weight ratio (HW/BW), myocardial lesions and cytokines production in a murine model of viral myocarditis induced by the encephalomyocarditis virus (EMCV). Four-week-old male DBA/2 mice were inoculated with the EMCV. To examine its effect on survival and HW/BW on day 14, mice were administered oral amiodarone (30 mg/kg) or the vehicle only once daily, starting 4 days before inoculation of the virus. The effects of amiodarone on histopathologic changes in myocardial lesions and myocardial cytokine production were studied in mice treated with amiodarone (10 mg/kg or 30 mg/kg) or vehicle, and killed day 7. The survival rate on day 14 was significantly higher in the amiodarone-treated mice than in the control mice. The HW/BW, histopathologic score of cellular infiltration and myocardial interleukin 6 concentration were significantly lower in the amiodarone-treated group than in the control group. Likewise, myocardial necrotic area was significantly smaller in the amiodarone group than in the control group. This study suggests that the beneficial effects of amiodarone in viral myocarditis may be mediated by decreasing interleukin 6 production in myocardial tissue. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 33 条
[1]
Elevated circulating levels of C-C chemokines in patients with congestive heart failure [J].
Aukrust, P ;
Ueland, T ;
Müller, F ;
Andreassen, AK ;
Nordoy, I ;
Aas, H ;
Kjekshus, J ;
Simonsen, S ;
Froland, SS ;
Gullestad, L .
CIRCULATION, 1998, 97 (12) :1136-1143
[2]
CHORDERA A, 1978, INT J CLIN PHARM TH, V16, P357
[3]
CXC-chemokines, a new group of cytokines in congestive heart failure -: possible role of platelets and monocytes [J].
Damås, JK ;
Gullestad, L ;
Ueland, T ;
Solum, NO ;
Simonsen, S ;
Froland, SS ;
Aukrust, P .
CARDIOVASCULAR RESEARCH, 2000, 45 (02) :428-436
[4]
NEGATIVE INOTROPIC EFFECTS OF CYTOKINES ON THE HEART MEDIATED BY NITRIC-OXIDE [J].
FINKEL, MS ;
ODDIS, CV ;
JACOB, TD ;
WATKINS, SC ;
HATTLER, BG ;
SIMMONS, RL .
SCIENCE, 1992, 257 (5068) :387-389
[5]
BENEFICIAL-EFFECTS OF LOW-DOSE AMIODARONE IN PATIENTS WITH CONGESTIVE CARDIAC-FAILURE - A PLACEBO-CONTROLLED TRIAL [J].
HAMER, AWF ;
ARKLES, LB ;
JOHNS, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (07) :1768-1774
[6]
LONG-TERM RESULTS OF AMIODARONE THERAPY IN PATIENTS WITH RECURRENT SUSTAINED VENTRICULAR-TACHYCARDIA OR VENTRICULAR-FIBRILLATION [J].
HERRE, JM ;
SAUVE, MJ ;
MALONE, P ;
GRIFFIN, JC ;
HELMY, I ;
LANGBERG, JJ ;
GOLDBERG, H ;
SCHEINMAN, MM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (02) :442-449
[7]
CONTINUOUS ACTIVATION OF GP130, A SIGNAL-TRANSDUCING RECEPTOR COMPONENT FOR INTERLEUKIN 6-RELATED CYTOKINES, CAUSES MYOCARDIAL HYPERTROPHY IN MICE [J].
HIROTA, H ;
YOSHIDA, K ;
KISHIMOTO, T ;
TAGA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4862-4866
[8]
SERUM INTERLEUKIN-6 LEVELS BECOME ELEVATED IN ACUTE MYOCARDIAL-INFARCTION [J].
IKEDA, U ;
OHKAWA, F ;
SEINO, Y ;
YAMAMOTO, K ;
HIDAKA, Y ;
KASAHARA, T ;
KAWAI, T ;
SHIMADA, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (06) :579-584
[9]
Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis [J].
Iwasaki, A ;
Matsumori, A ;
Yamada, T ;
Shioi, T ;
Wang, WZ ;
Ono, K ;
Nishio, R ;
Okada, M ;
Sasayama, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) :1400-1407
[10]
ELEVATED CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR IN SEVERE CHRONIC HEART-FAILURE [J].
LEVINE, B ;
KALMAN, J ;
MAYER, L ;
FILLIT, HM ;
PACKER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (04) :236-241